Treating severe psoriasis: an update.
This article provides an overview of the common skin condition psoriasis, and the various treatments that are available, which include the newly available biologic drugs for severe psoriasis. It examines quality of life issues, including the rejection and stigmatisation felt by many patients, and explores coping strategies that can help patients.
Ronda
Lucy
L
Skin Therapy Research Unit, St John's Institute of Dermatology, Guy's and St Thomas' Hospital, London.
Jones
Liz
L
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010353:Patient Education as Topic / Q000379:methods; D010789:Phototherapy / Q000379:methods / Q000451:nursing; D011565:Psoriasis / Q000503:physiopathology / Q000628:therapy*; D011788:Quality of Life
D000911:Antibodies, Monoclonal; D000963:Antimetabolites; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents